Vistatec Life Sciences — In Focus Episode 16 with Eloise Moffett

Square

Vistatec Life Sciences - In Focus Podcast Ep 16 - Eloise Moffett

“Sometimes, going back to basics is the boldest move you can make.” That sentiment perfectly captures the perspective shared by Eloise Moffett, Vice President of Commercial at Innovative Trials, in the latest episode of the Life Sciences – In Focus podcast.

From cultural nuance in global patient engagement to bold marketing campaigns that make a meaningful impact, Eloise brings passion, creativity, and authenticity to her role and the wider clinical trials landscape.

From Travel to Trials: A Nonlinear Path with Purpose

Eloise’s career path is a testament to how diverse experience can shape effective leadership. After 17 years in the travel industry, she pivoted into patient recruitment and retention, bringing a deep understanding of human behavior, global cultural differences, and bold creativity in marketing. These are skills she now leverages at Innovative Trials.

Today, as part of the company’s leadership team, Eloise oversees Sales, Marketing, Contracts, and Proposals, ensuring that every touchpoint with clients and clinical sites reflects Innovative Trials’ commitment to site-level support, patient-centricity, and strategic recruitment.

What Sets Innovative Trials Apart?

Headquartered in the UK with a presence in more than 70 countries, Innovative Trials is a global leader in accelerating patient recruitment and improving retention through tailored, site-specific strategies. “Our strength lies not just in being local, but in being culturally competent,” Eloise said during the episode. “It’s one thing to speak the language, but understanding the culture, that’s where the difference is made.”

Whether it’s crafting custom patient materials, providing one-on-one support to clinical sites, or managing digital advertising strategies, Innovative Trials’ approach is rooted in deep collaboration with both sponsors and sites. As Eloise emphasized, “We believe in AI, but we lead with relationships.”

Relationship-Driven, Globally Conscious

A key differentiator for Innovative Trials is their hands-on, site-level engagement. Eloise described their Clinical Enrollment Managers as experts embedded in-country who work directly with trial sites to troubleshoot recruitment challenges and design effective plans.

Why such a high-touch model? “Every site is different, even within the same country. That nuance is critical,” Eloise explained.

In addition to core services in patient recruitment and retention, the company offers a Navigator Service that supports patients both before screening and during the clinical trial journey. As Eloise shared, “It’s not just about retaining participants. It’s about supporting them. That distinction matters.”

Bold Marketing, With Meaning

Anyone who has attended the SCOPE Summit for Clinical Ops Executives will have noticed Innovative Trials’ unforgettable booths. From Back to the Future-themed designs to heartfelt collaborations with the Oliver Patch Project, their event presence is far from ordinary.

But make no mistake, there’s strategic thinking behind the splash. “Creativity without purpose is just noise,” said Eloise. “We make sure our booth concepts align with the messaging that matters, whether it’s taking things back to basics or highlighting support for pediatric patients in clinical trials.”

Eye on the Future: Trends and Transitions in 2025

Looking ahead, Eloise identified two key shifts in clinical research:

Global Expansion of U.S. Sponsors

U.S.-based clients are increasingly seeking support beyond domestic borders. Innovative Trials is stepping up its visibility to showcase its global capabilities.

The AI Conversation

Artificial intelligence is a hot topic, but Eloise offers a pragmatic take. “Used well, AI can enhance what we do. But it can’t replace human connection. The best tools still need people to guide them.”

Eloise was clear about regulatory uncertainty and political noise, especially in the U.S.. “We carry on. Diversity isn’t about politics. It’s about good science. It’s about making sure trial populations reflect the real world.”

SCRS, Scope, and the Year Ahead

2025 marks Innovative Trials’ 15th anniversary, and they’ll be celebrating at SCRS Global Site Solutions Summit in September. Unlike most conferences, SCRS is where the team goes to listen and learn, to connect with trial sites and continue evolving their services.

They’ll be at booth #911, a number they’re already having some fun with. As Eloise quipped, “We’ve got plans. Just wait and see.”

Yes, the Back to Basics theme will make a return. But next year’s SCOPE? Expect a fresh take!

Eloise Moffett is the kind of leader who reminds us why this work matters. In her words: “It’s easy to feel like, in sales, you’re just selling something. But when you’re helping patients, supporting sites, and getting treatments to market, that’s a different kind of impact. That’s purpose.”

We couldn’t agree more.

About Life Sciences – In Focus

Life Sciences – In Focus Podcast by Visatatec, a fascinating conversation with global life sciences experts. The show has multiple hosts and topics. Follow Life Sciences – In Focus on Spotify for all the latest episodes, or subscribe to the show on YouTube and Apple podcasts. Life Sciences – In Focus is available on many other podcast platforms. To learn more about the podcast, please visit https://vistatec.com/life-sciences-division.

About Vistatec 

We have been helping some of the world’s most iconic brands to optimize their global commercial potential since 1997. Vistatec is one of the world’s leading global content solutions providers. HQ in Dublin, Ireland, with offices in Mountain View, California, USA. To learn more about Vistatec, please visit https://www.vistatec.com